{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:39:31Z","timestamp":1791211171385,"version":"4.1.0"},"reference-count":43,"publisher":"Informa UK Limited","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Vaccines & Immunotherapeutics"],"published-print":{"date-parts":[[2012,9,16]]},"DOI":"10.4161\/hv.20518","type":"journal-article","created":{"date-parts":[[2012,8,20]],"date-time":"2012-08-20T10:25:11Z","timestamp":1345458311000},"page":"1335-1353","source":"Crossref","is-referenced-by-count":21,"title":["Overview of cancer vaccines"],"prefix":"10.1080","volume":"8","author":[{"given":"Alex","family":"Kudrin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2014,11,4]]},"reference":[{"key":"R1","first-page":"14","volume":"12","author":"Copier J","year":"2010","journal-title":"Curr Opin Mol Ther"},{"key":"R2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.12.017"},{"key":"R3","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.06.041"},{"key":"R4","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.09.012"},{"key":"R5","doi-asserted-by":"publisher","DOI":"10.1038\/nature10673"},{"key":"R6","doi-asserted-by":"crossref","unstructured":"Vergati M, Intrivici C, Huen NY, Schlom J, Tsang KY. Strategies for Cancer Vaccine Development. J Biomed Biotechnol 2010: 13 p.","DOI":"10.1155\/2010\/596432"},{"key":"R10","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2011.10.027"},{"key":"R12","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2008.09.006"},{"key":"R13","doi-asserted-by":"publisher","DOI":"10.1038\/sj.clpt.6100369"},{"key":"R14","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-011-0985-7"},{"key":"R15","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2012.13"},{"key":"R16","first-page":"187","author":"Nishizawa S","year":"2012","journal-title":"J Urol"},{"key":"R17","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2112"},{"key":"R18","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1239"},{"key":"R19","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgp127"},{"key":"R20","doi-asserted-by":"publisher","DOI":"10.1159\/000333470"},{"key":"R23","doi-asserted-by":"publisher","DOI":"10.1080\/07357900701206281"},{"key":"R24","first-page":"29","author":"Pfisterer JS","year":"2011","journal-title":"J Clin Oncol"},{"key":"R25","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djr343"},{"key":"R29","doi-asserted-by":"publisher","DOI":"10.1038\/icb.2011.100"},{"key":"R30","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3237"},{"key":"R31","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2010.223"},{"key":"R32","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbpa.2010.06.170"},{"key":"R38","doi-asserted-by":"publisher","DOI":"10.1038\/nbt0209-129"},{"key":"R44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2011.09.018"},{"key":"R58","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1100548"},{"key":"R59","doi-asserted-by":"publisher","DOI":"10.1177\/009286151104500306"},{"key":"R61","doi-asserted-by":"publisher","DOI":"10.3892\/ijo_00000619"},{"key":"R63","first-page":"3321","volume":"24","author":"Egawa K","year":"2004","journal-title":"Anticancer Res"},{"key":"R66","first-page":"81","volume":"48","author":"Maekawa T","year":"2005","journal-title":"JMAJ"},{"key":"R68","unstructured":"Landsdell M. Innovative drug discovery in emerging markets. Business Insights, 2011."},{"key":"R74","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2728"},{"key":"R75","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djq310"},{"key":"R76","doi-asserted-by":"publisher","DOI":"10.1097\/01.cji.0000211341.88835.ae"},{"key":"R77","first-page":"711","volume":"8","author":"Ogino S","year":"2011","journal-title":"Clin Oncol"},{"key":"R78","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-008-0665-y"},{"key":"R79","doi-asserted-by":"publisher","DOI":"10.1038\/nrurol.2010.84"},{"key":"R80","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1001294"},{"key":"R81","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-1624"},{"key":"R84","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2012.02.765"},{"key":"R85","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.13.011"},{"key":"R86","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2009.295"},{"key":"R87","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2010.221127"}],"container-title":["Human Vaccines & Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.4161\/hv.20518","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T20:10:54Z","timestamp":1562098254000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/abs\/10.4161\/hv.20518"}},"subtitle":["Considerations for development"],"short-title":[],"issued":{"date-parts":[[2012,9,16]]},"references-count":43,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2014,11,4]]},"published-print":{"date-parts":[[2012,9,16]]}},"alternative-id":["10.4161\/hv.20518"],"URL":"https:\/\/doi.org\/10.4161\/hv.20518","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,16]]}}}